Insights Library

Review our latest comprehensive white papers, informative webinars, and illuminating case studies.

SR-Pharmacokinetics-Hero-1

White Papers

Learn more about our expertise

Efficient Drug Discovery Powered by High Accuracy A.I. Models
Download our white paper to discover how Southern Research accelerates drug discovery through innovative practices.

 

Ensuring the Safety of Novel Viral Vector Platforms
Download our white paper to learn how we assess neurovirulence and neurotoxicity for responsible development of viral-based medicines.

 

Mission Ready: Prepared to Respond to the Next Pandemic
Download our white paper to learn how Southern Research provides expertise in developing new treatments against seasonal influenza.

CASE STUDY: Southern Research Enables Fortune 500 Pharmaceutical Company to Rapidly File IND Application

A Fortune 500 pharmaceutical company approached SR about testing a prophylactic molecule in reducing or preventing influenza infection in a ferret model. Download the case study here to learn more.

CASE STUDY: Southern Research Successfully Tests BioNTech MPXV Vaccine in NHPs

German biotechnology company BioNTech SE approached Southern Research to test the efficacy of their prophylactic (mRNA vaccine) against highly pathogenic MPXV Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

CASE STUDY: Southern Research Enables Accelerated Timeline for Pharmaceutical Company’s Therapeutics for Monkeypox Virus

A medium-sized pharmaceutical company approached Southern Research (SR) to test the efficacy of their therapeutic molecules against highly pathogenic MPXV, Zaire strain in non-human primates (NHPs). Download the case study here to learn more.

SR-Oncology-Webinar-Graphic-Image-1

Oncology Webinar

The tumor immune microenvironment (TIME) plays a major role in tumor progression, therapy response, and ultimate prognosis. Therefore, key cells, pathways, and proteins within the TIME are being evaluated as targets for new cancer drugs. Watch as Dr. Rebecca Boohaker, our Director of Oncology, highlights progress in three drug discovery initiatives that use this interdisciplinary approach to target immune suppression in the TIME.

Watch Now

Southern Research News

Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

Southern Research Awarded Grant to Develop Novel Antidotes for Arsenical Poisoning

April 11, 2024

Project Aims to Deliver Safer and More Effective Treatments for Cutaneous Injuries Southern Research is pleased to announce the award of a UG3/UH3 grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health (N...
Read More
Radyus Research Forges Strategic Partnership with Southern Research to Propel Life Sciences Commercialization

Radyus Research Forges Strategic Partnership with Southern Research to Propel Life Sciences Commercialization

March 13, 2024

Radyus Research, a global drug development organization from Atlanta, Georgia, is excited to announce a pivotal strategic partnership with Southern Research, a Birmingham-based contract research organization with more than 80 years of experience in drug discovery and development. This partners...
Read More
Southern Research opens new Station 41 biotech incubator for startups

Southern Research opens new Station 41 biotech incubator for startups

January 23, 2024

Today, Southern Research marked the official opening of its Station 41 biotech incubator, which is one of four programs that make up the newly launched Station 41 biotech commercialization hub. The incubator provides wet lab space and office space, shared lab equipment and services to support ...
Read More

© 2024 Southern Research. All rights reserved.